Patient Safety Risk
The Food and Drug Administration today required certain COVID-19 test developers to evaluate how SARS-CoV-2 mutations impact their test’s performance and update the labeling for the product accordingly.
Medical Action Industries Inc. has recalled more than 8,000 medical convenience kits due to fungal contamination risk from an applicator used to sanitize skin prior to wound care, catheter procedures and blood collection
.webreplay{
border: solid 2px #777;
padding: 15px 5px;
margin: 0 0 10px 15px;
}
@media (min-width:360px){
.webreplay{
min-width: 290px;
float: right;
}
}
On-demand Webinar
MktoForms2.loadForm("//sponsored.aha.org", "734-ZTO-041", 5839);
Patient Safety Organization…
A new report from the Agency for Healthcare Research and Quality consolidates the latest evidence on 47 patient safety practices to help hospitals, primary care practices, long-term care facilities and other providers target and focus their patient safety efforts.
A federal court in Texas yesterday ordered Pharm D Solutions to stop producing or distributing compounded drugs intended to be sterile until the company complies with federal law and other requirements, the Food and Drug Administration announced.